GABELLI FUNDS LLC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 176 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$835,000
-37.2%
100,0000.0%0.01%
-30.0%
Q2 2023$1,330,000
+14.9%
100,0000.0%0.01%
+11.1%
Q1 2023$1,158,000
+41.6%
100,0000.0%0.01%
+50.0%
Q4 2022$818,000
+40.8%
100,0000.0%0.01%
+20.0%
Q3 2022$581,000
+21.3%
100,000
-7.7%
0.01%
+25.0%
Q2 2022$479,000
-74.1%
108,302
-46.6%
0.00%
-66.7%
Q1 2022$1,847,000
-55.5%
203,0000.0%0.01%
-53.8%
Q4 2021$4,153,000
+52.5%
203,000
-26.4%
0.03%
+23.8%
Q3 2020$2,724,000
-66.3%
276,000
-88.2%
0.02%
-68.2%
Q2 2020$8,076,000
+11.5%
2,340,887
-1.1%
0.07%
+1.5%
Q1 2020$7,246,000
-42.2%
2,367,887
-3.0%
0.06%
-19.8%
Q4 2019$12,541,000
-13.1%
2,439,898
-12.8%
0.08%
-14.7%
Q3 2019$14,434,000
-16.5%
2,797,259
-2.1%
0.10%
-14.4%
Q2 2019$17,289,000
-17.5%
2,857,745
-1.5%
0.11%
-15.9%
Q1 2019$20,968,000
+62.4%
2,900,106
+66.2%
0.13%
+48.3%
Q4 2018$12,909,0001,744,4700.09%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q3 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,660,000$24,206,00011.49%
Data Collective II GP, LLC 164,249$1,495,0005.44%
Decheng Capital Management III (Cayman), LLC 1,463,872$13,321,0004.08%
SB Management Ltd 1,886,107$17,164,0003.33%
Casdin Capital, LLC 7,990,652$72,715,0003.26%
ORACLE INVESTMENT MANAGEMENT INC 1,225,395$11,151,0002.20%
Jackson Square Partners, LLC 22,542,589$205,137,0002.04%
BOURNE LENT ASSET MANAGEMENT INC 556,865$5,067,0001.59%
ARK Investment Management 27,259,521$248,062,0001.04%
Nikko Asset Management Americas, Inc. 14,021,205$127,873,0000.94%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders